The DOI matches its Crossref record; 152 of the 155 references it cites were found in a registry or an index.
Monocyte-Macrophages and T Cells in Atherosclerosis
Open accessAbstract
Atherosclerosis is an arterial disease process characterized by the focal subendothelial accumulation of apolipoprotein-B-containing lipoproteins, immune and vascular wall cells, and extracellular matrix. The lipoproteins acquire features of damage-associated molecular patterns and trigger first an innate immune response, dominated by monocyte-macrophages, and then an adaptive immune response. These inflammatory responses often become chronic and non-resolving and can lead to arterial damage and thrombosis-induced organ infarction. The innate immune response is regulated at various stages, from hematopoiesis to monocyte changes and macrophage activation. The adaptive immune response is regulated primarily by mechanisms that affect the balance between regulatory and effector T cells. Mechanisms related to cellular cholesterol, phenotypic plasticity, metabolism, and aging play key roles in affecting these responses. Herein, we review select topics that shed light on these processes and suggest new treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immunosuppressive drug regimens may have adverse effects on lipid metabolism leading to increases in TC, VLDL, and TGs, and in the size and density of LDL particles.”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [502]
In the citing paper
“These effects vary with different immunosuppressive drugs [497,498,502-506].”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [502]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Ridker, P. M., Everett, B. M., Thuren, T., MacFadyen, J. G., Chang, W. H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S. D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707914 · Cited by 9,482
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Wang, Z., Klipfell, E., Bennett, B. J., Koeth, R., Levison, B. S., DuGar, B., Feldstein, A. E., Britt, E. B., Fu, X., Chung, Y.-M., et al. (2011) · Nature · doi:10.1038/nature09922 · Cited by 5,597
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,880
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841
Cytokine-mediated regulation of CXCR4 expression in human neutrophils
Nagase, H., Miyamasu, M., Yamaguchi, M., Imanishi, M., Tsuno, N. H., Matsushima, K., Yamamoto, K., Morita, Y., & Hirai, K. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.711 · Cited by 4,713
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026 · cited 1×
“Although cholesterol crystals have been implicated in this process (Duewell et al., 2010; Sheedy et al., 2013), other mechanisms are likely to contribute as well (Hoseini et al., 2017).”
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,094
Trained immunity: A program of innate immune memory in health and– disease
Netea, M. G., Joosten, L. A. B., Latz, E., Mills, K. H. G., Natoli, G., Stunnenberg, H. G., O’Neill, L. A. J., & Xavier, R. J. (2016) · Science · doi:10.1126/science.aaf1098 · Cited by 2,768
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683
Lakatta, E. G., & Levy, D. (2003) · Circulation · doi:10.1161/01.cir.0000048892.83521.58 · Cited by 2,244
Flagged first, then by citations
3 of the 155 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–500 of 650
Cui, X., Xing, R., Tian, Y., Wang, M., Sun, Y., Xu, Y., Yang, Y., Zhao, Y., Xie, L., Xiao, Y., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.659211 · Cited by 7
Talepoor, A. G., Rastegari, B., Kalani, M., & Doroudchi, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108295 · Cited by 9
Meneri, M., Bonato, S., Gagliardi, D., Comi, G. P., & Corti, S. P. (2022) · Biomedicines · doi:10.3390/biomedicines10071693 · Cited by 7
Jiang, L., Zhu, T., Tang, K., Wu, Y., Fu, M., Ji, J., Mi, Q., Ge, P., Zhao, X.-H., Tai, T., et al. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.01.028 · Cited by 7
Bondy, S. C. (2023) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-26576-1_13 · Cited by 7
Roles of extracellular vesicles derived from immune cells in atherosclerosis
Qiao, K., Cui, X., Gao, J., Yu, F., Liu, H., Dai, Y., Liu, J., Yang, Y., Xian, X., Hu, J.-M., et al. (2023) · Extracellular Vesicle · doi:10.1016/j.vesic.2023.100028 · Cited by 4
Rodríguez-Carrio, J., Carrillo-López, N., Ulloa, C., Martín-Carro, B., Rodríguez-Suárez, C., Naves-Díaz, M., Sánchez-Álvarez, E., Rodríguez-García, M., Arcidiacono, M., Fernández-Mariño, B., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.618286 · Cited by 9
Molecular mechanisms linking adipose tissue browning to reduced cardiovascular risk
Checa-Ros, A., & D’Marco, L. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120564 · Cited by 6
Cheng, G., Liu, Y., Xing, Y., Shi, Z., Farag, M. A., Jin, S., & Xia, B. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.01.007 · Cited by 6
Sekenova, A., Li, Y., Issabekova, A., Saparov, A., & Ogay, V. B. (2023) · Cells · doi:10.3390/cells12182262 · Cited by 6
The Impact of the Apolipoprotein E Genotype on Cardiovascular Disease and Cognitive Disorders
McMaster, M. W., Shah, A., Kangarlu, J., Cheikhali, R., Frishman, W. H., & Aronow, W. S. (2024) · Cardiology in Review · doi:10.1097/crd.0000000000000703 · Cited by 9
Chen, X., Cheng, S., Huang, L., Chen, X., Jin, N., Hong, J. Y., Zhao, X., & Rong, J. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.05.023 · Cited by 6
Blood Microbiota and Its Products: Mechanisms of Interference with Host Cells and Clinical Outcomes
Santacroce, L., Charitos, I. A., Colella, M., Palmirotta, R., & Jirillo, E. (2024) · Hematology Reports · doi:10.3390/hematolrep16030043 · Cited by 6
Hirpara, A., Ackert‐Bicknell, C. L., & Patel, V. V. (2024) · Spine · doi:10.1097/brs.0000000000005217 · Cited by 6
Adipose tissue macrophages and atherogenesis – a synergy with cholesterolaemia
Poledne, R., & Lesná, I. K. (2021) · Physiological Research · doi:10.33549/physiolres.934745 · Cited by 6
Wang, Z., Zhang, X., Zhang, C., Li, Y., Lu, S., Mohanta, S. K., Weber, C., Habenicht, A. J. R., & Yin, C. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1924-7_44 · Cited by 6
Sun, T., Wang, F., He, Y., Mao, B., Han, M., Liu, H., Zhao, P., Li, X., & Wang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.900642 · Cited by 6
Understanding the role of alternative macrophage phenotypes in human atherosclerosis
Kawai, K., Vozenilek, A. E., Kawakami, R., Sato, Y., Ghosh, S., Virmani, R., & Finn, A. V. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2111301 · Cited by 6
Feng, L., Deng, C., & Li, Y. (2018) · Disease Markers · doi:10.1155/2018/3793768 · Cited by 6
Zhong, Z., Zhang, Q., Tan, L., Guo, X., & Gan, C. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-7342 · Cited by 6
Incretin Hormones in the Control of Immunometabolism
Fishman, S., Zvibel, I., & Varol, C. (2019) · Immunometabolism · doi:10.20900/immunometab20190004 · Cited by 6
Inflammation and atherosclerosis: fulfilling Koch’s postulates
Jialal, I., & Vikram, N. K. (2017) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944717744740 · Cited by 6
Zhang, H., & Reilly, M. P. (2018) · Circulation Research · doi:10.1161/circresaha.118.314006 · Cited by 6
Identification of a PRDM1-regulated T cell network to regulate atherosclerotic plaque inflammation
Jin, H., Maas, S. L., Zou, Y., Lu, C., Yu, B., Huchzermeier, R., Nadeau, S., Santos, J. D., Gijbels, M. J., Mees, B., et al. (2025) · Genome Medicine · doi:10.1186/s13073-025-01541-6 · Cited by 5
Miceli, G., Ciaccio, A. M., Cuffaro, M., Profita, M., & Tuttolomondo, A. (2025) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2025.2575449 · Cited by 6
Zhang, X., Chen, Y., Ling, Y., Wu, L., Liu, D., Wang, L., Liu, Y., Shi, G., Zhou, B., Hao, B., et al. (2025) · MedComm · doi:10.1002/mco2.70439 · Cited by 5
Immune-mediated interactions between sarcopenia and atherosclerosis in aging
Yu, M., Zhao, R., Ge, L.-C., Yu, T., Shen, H., Dai, C., & Wang, H. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00537-5 · Cited by 7
Decoding Vascular Cell Diversity: Single-Cell Approaches to Mechanisms of Vascular Disease
Schwartzman, W. E., Jiang, J., Rao, J. S., Schnitzler, G. R., Maurya, M., Widdup, L., Pepin, M. E., Kang, H. Y., Zheng, C. X., & Gupta, R. M. (2026) · Circulation Research · doi:10.1161/circresaha.125.326001 · Cited by 6
Zhang, Y.-J., Huang, C., Zu, X., Liu, J., & Li, Y. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s439315 · Cited by 5
Su, X., Zhang, M., Yang, G., Cui, X., Yuan, X., Du, L., & Pei, Y. (2024) · Medicine · doi:10.1097/md.0000000000038744 · Cited by 5
Tsioulos, G., Vallianou, N. G., Skourtis, A., Dalamaga, Μ., Kotsi, E., Kargioti, S., Adamidis, N., Karampela, Ι., Mourouzis, I. S., & Kounatidis, D. C. (2024) · Biomolecules · doi:10.3390/biom14121637 · Cited by 6
Zhang, Q., Zheng, P., Pan, Y., Zhou, H., Fu, Y., & Jia, E. (2025) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2024.12.007 · Cited by 6
Exosomal non-coding RNAs: key regulators of inflammation-related cardiovascular disorders
Saadh, M. J., Muhammad, F. A., Albadr, R. J., Sanghvi, G. V., Ballal, S., Pathak, P. K., Bareja, L., Aminov, Z., Taher, W. M., Alwan, M., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-02649-6 · Cited by 5
Analysis of In Vivo Serpin Functions in Models of Inflammatory Vascular Disease
Chen, H., Ambadapadi, S., Dai, E., Liu, L., Yaron, J. R., Zhang, L., & Lucas, A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8645-3_11 · Cited by 5
Braunlin, E., Abrahante, J. E., McElmurry, R. T., Evans, M. D., Smith, M. C., Seelig, D. M., O’Sullivan, M. G., Tolar, J., Whitley, C. B., & McIvor, R. S. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.01.104 · Cited by 5
Lu, R., Wang, W., Dong, B., Xu, C. Y., Li, B., Sun, Y., Liu, J., & Hong, B. (2022) · Molecules · doi:10.3390/molecules27238134 · Cited by 6
Zhu, X., Xu, H., & Chen, B. (2023) · Immunity Inflammation and Disease · doi:10.1002/iid3.785 · Cited by 5
Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management
Good, E., Åkerman, L., Nyström, S. N., Jonasson, L., Ernerudh, J., & de Muinck, E. D. (2023) · Scientific Reports · doi:10.1038/s41598-023-48111-7 · Cited by 5
Liu, H., Li, J., Wu, N., She, Y., Luo, Y., Huang, Y., Quan, H., Fu, W., Li, X., Zeng, D., et al. (2024) · Inflammation · doi:10.1007/s10753-023-01932-0 · Cited by 5
Ning, D.-S., Zhou, Z., Zhou, S.-H., & Chen, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e34295 · Cited by 5
Karere, G. M., Dick, E. J., Galindo, S., Martinez, J. C., Martinez, J. E., Owston, M. A., VandeBerg, J. L., & Cox, L. A. (2019) · Journal of Medical Primatology · doi:10.1111/jmp.12449 · Cited by 5
Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate model
Cataldo, V. D., Debatisse, J., Agudelo, J. P., Géloën, A., Grandin, C., Verset, M., Taborik, F., Labaronne, E., Loizon, E., Millon, A., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab064 · Cited by 5
Montanaro, M., Scimeca, M., Toschi, N., Bonanno, E., Giacobbi, E., Servadei, F., Ippoliti, A., Santeusanio, G., Mauriello, A., & Anemona, L. (2021) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000947 · Cited by 5
Yu, J., Ruan, Q., Nie, X., Yu, L., & Huang, B. (2020) · Journal of Biomaterials Applications · doi:10.1177/0885328220905181 · Cited by 5
Shiber, S., Kliminski, V., Orvin, K., Sagy, I., Vaturi, M., Kornowski, R., Drescher, M. J., & Molad, Y. (2021) · Mediators of Inflammation · doi:10.1155/2021/8872686 · Cited by 5
Inhibition of IL17A Using an Affibody Molecule Attenuates Inflammation in ApoE-Deficient Mice
Kumawat, A. K., Zegeye, M. M., Paramel, G. V., Baumgartner, R., Gisterå, A., Amegavie, O., Hellberg, S., Jin, H. H., Caravaca, A. S., Söderström, L. Å., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.831039 · Cited by 4
Xu, Q., Liu, Z., Chen, Y., Qin, L., Zhao, M., Tang, W., Chen, S., Zhang, Y., & Zhong, Q. (2024) · Environmental Pollution · doi:10.1016/j.envpol.2024.124493 · Cited by 4
Immunologic and inflammatory pathogenesis of chronic coronary syndromes: A review
Chen, T., & Yang, Y. (2024) · Medicine · doi:10.1097/md.0000000000040354 · Cited by 4
The sentinels of coronary artery disease: heterogeneous monocytes
Chen, Y., Luo, D., Gao, R., Wu, J., Qiu, X., Zou, Y., Jian, Y., & Zhang, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1428978 · Cited by 4
Impaired CAMK4 Activity Limits Atherosclerosis and Reprograms Myelopoiesis
Gonzalez, A. L., Youwakim, C. M., Leake, B. F., Fuller, K., Rahman, S. M. J., Dungan, M. M., Gu, K., Bonin, J. L., Cavnar, A. B., Michell, D. L., et al. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.322530 · Cited by 4
Wu, X., 施慧华, Li, B., Dong, B., Lu, R., Lu, X., Chen, Y., & Lu, X. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb01423a · Cited by 4
Desouky, M. A., El‐Magd, M. A., Mousa, M. A., Mallick, A. H., Khan, D., & Desouky, D. A. (2025) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-025-00694-y · Cited by 4
Sun, D., Hu, D., Wang, J., Peng, J., & Wang, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209996 · Cited by 4
Qiu, Z., Wang, R.-Y., Zhang, Y., Huang, H.-B., He, R.-Y., Yan, H., Luo, P., Yang, B., Xu, Z.-F., & He, Q.-J. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01729-x · Cited by 6
Shen, S., Mohan, A. A., Hotchkiss, K. M., Cook, S. L., Patel, K., Moelker, E., Puviindran, B. J., Gonzalez, A. T., Zaidi, S. E., Spellicy, S. E., et al. (2026) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-012532 · Cited by 5
van Os, B. W., Kusters, P. J. H., den Toom, M., Beckers, L., van Tiel, C. M., Vos, W. G., de Jong, E. A. M., Kieser, A., van Roomen, C. P. A. A., Binder, C. J., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1171764 · Cited by 4
PDL-1 and insulin resistance in obesity: a possible pathway for macrovascular disease
Abdalla, M., El‐Arabey, A. A., & Gai, Z. (2024) · Human Cell · doi:10.1007/s13577-024-01029-2 · Cited by 4
Василенко, В. С., Вадимович, Л. З., Карповская, Е. Б., & Semenova, Y. B. (2020) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202023031113 · Cited by 4
Hydrogel-Based Therapies for Cardiovascular Diseases
Patil, R., Rajput, A., Dewani, M., Mehta, S., Ahamad, N., & Banerjee, R. (2021) · Springer eBooks · doi:10.1007/978-981-16-4420-7_16 · Cited by 4
Potashnikova, D. M., Saidova, A. A., Tvorogova, A. V., Anisimova, A. S., Botsina, A. Y., Vasilieva, E., & Margolis, L. B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.891916 · Cited by 4
Pan, H., Wu, T., Huang, K., Guo, Z., Liang, H., Lyu, P., Huang, H., Feng, X., Wang, Q., Hu, J., et al. (2024) · Translational research · doi:10.1016/j.trsl.2024.01.004 · Cited by 4
The novel vaccines targeting interleukin-1 receptor type I
Zhou, Y., Huang, J., Mai, W., Kuang, W., Li, X., Shi, D., Yang, Y., Wu, J., Wu, Z., Liao, Y., et al. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111941 · Cited by 7
Rey, N., Ebrahimian, T. G., Gloaguen, C., Kereselidze, D., Christelle, E., Brizais, C., Bachelot, F., Riazi, G., Monceau, V., Demarquay, C., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-63084-x · Cited by 4
Co-repressing immunometabolic processes in atherosclerosis
Stein, S. (2022) · Cardiovascular Medicine · doi:10.4414/cvm.2021.02142 · Cited by 4
Communicating with the dead: lipids, lipid mediators and extracellular vesicles
Devitt, A., Griffiths, H. R., & Milic, I. (2018) · Biochemical Society Transactions · doi:10.1042/bst20160477 · Cited by 4
Progression of Multifaceted Immune Cells in Atherosclerotic Development
Park, S., & Lee, I. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.1.15 · Cited by 4
Reitsema, R. D., Kurt, S., Rangel, I., Hjelmqvist, H., Dreifaldt, M., Sirsjö, A., & Kumawat, A. K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1568431 · Cited by 3
Junior, C. V. S., Ribeiro, M. D. O. L., Bichuette, L. D., Scarpa, B. R., Severino, P., Gollob, K. J., Lima, J. A. C., & Libby, P. (2025) · Einstein (São Paulo) · doi:10.31744/einstein_journal/2025rw1780 · Cited by 3
Li, Y., Leberzammer, J., Blanchet, X., Duan, R., Lacy, M., Triantafyllidou, V., Eckardt, V., Briem, E., Jung, A. S., Su, R. J., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120608 · Cited by 3
Colchicine in cardiovascular medicine: Current perspectives on mechanisms and clinical therapeutics
Ding, H., Cheng, C. K., Jiang, M., Cheng, X., & Huang, Y. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.109053 · Cited by 3
Loss of CD226 protects apolipoprotein E-deficient mice from diet-induced atherosclerosis
Zhang, Y., Xu, X., Ma, J., Liu, Y., Duan, C., Liu, Y., Feng, C., Li, W., Wang, Y., Cheng, K., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166452 · Cited by 3
LncRNA SCARNA8 promotes atherosclerotic plaque instability by inhibiting macrophage efferocytosis
Yin, X., Chen, X., Wang, T., Yang, J., Yu, J., & Yang, J. (2025) · Epigenetics · doi:10.1080/15592294.2025.2487317 · Cited by 3
Kooshesh, K. A., Foy, B. H., Baylis, R. A., Gustafsson, K., Zlotoff, D. A., Neilan, T. G., & Scadden, D. T. (2025) · Blood Advances · doi:10.1182/bloodadvances.2024015286 · Cited by 3
Yang, J., Zhong, J., Du, Y., Liu, J., Li, Z., & Liu, Y. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112811 · Cited by 4
Dziedzic, E. A., Czernicka, A., Gąsior, J. S., Szamreta-Siwicka, A., Wodejko-Kucharska, B., Maciński, P., Arbaszewska, A., Adler, K., Osiecki, A., & Kochman, W. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14134537 · Cited by 3
Circulating Monocyte Populations in Patients With Coronary Atherosclerosis
Filatova, A. Y., Potekhina, A. V., Radyukhina, N. V., Ruleva, N. Y., Проваторов, С. И., & Arefieva, T. I. (2022) · Future Cardiology · doi:10.2217/fca-2021-0042 · Cited by 3
Association of Common Variants in OLA1 Gene with Preclinical Atherosclerosis
Lin, T.-F., Chou, C., Hsieh, C.-J., Wu, Y., Chen, Y.-C., Wu, T., Lu, S.-X., Juang, Y., & Wang, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911511 · Cited by 3
Li, S., Zhang, Q., Weng, L., & Li, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1014264 · Cited by 3
Repeated lipoprotein apheresis and immune response: Effects on different immune cell populations
Walther, R., Wehner, R., Tunger, A., Julius, U., Schatz, U., Tselmin, S., Bornstein, S. R., Schmitz, M., & Graessler, J. (2022) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13886 · Cited by 3
New approaches to pathogenetic anti-inflammatory therapy of cardiovascular diseases
Павловна, К. Е., Maslyanskiy, А. L., Rotar, О. P., Конради, А. О., & Vi, M. (2023) · HERALD of North-Western State Medical University named after I I Mechnikov · doi:10.17816/mechnikov296331 · Cited by 3
Li, Z., Liu, J., Liu, Z., Zhu, X., Geng, R., Ding, R., Xu, H., & Huang, S. (2024) · Aging · doi:10.18632/aging.205566 · Cited by 3
Jin, T., Gao, H., Meng, D., Luo, M., & Hu, J. J. (2024) · Open Medicine · doi:10.1515/med-2024-1072 · Cited by 3
Zhao, N., Liu, D., Song, H., Zhang, X., Yan, C., & Han, Y. (2025) · Scientific Reports · doi:10.1038/s41598-024-83925-z · Cited by 3
Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_10 · Cited by 3
Mesenchymal Stem Cells: A Potential Promise in Treating Atherosclerosis?Preprint
Zhang, X., Wang, J., Colello, J., & Zheng, S. G. (2018) · Preprints.org · doi:10.20944/preprints201808.0149.v1 · Cited by 3
Monocyte subsets as predictors of adverse events in patients with atherosclerosis
Frangogiannis, N. G. (2019) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2019.11.009 · Cited by 3
From the vulnerable plaque to the vulnerable patient: Current concepts in atherosclerosis
Sage, A. P., & Antoniades, C. A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15347 · Cited by 4
Editorial: Nuclear Receptors and Coregulators in Metabolism and Immunity
Fan, R., Pineda‐Torra, I., & Venteclef, N. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.828635 · Cited by 3
Yang, L., Wei, Q., Guo, J., Xu, X., Zhu, L., Zhang, Z., Zhou, J., Dong, Y., Wei, D., Wen, Y., et al. (2025) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2025.114675 · Cited by 2
Immunomodulatory strategies and targeted delivery systems in atherosclerosis therapy
Jiang, W., Tang, H., Hu, Y., Sun, J., Lou, Z., Qu, P., & Liu, Q. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2636761 · Cited by 2
Artery tertiary lymphoid organs, neuro-immune interaction and their mediators in atherosclerosis
Ortona, S., Ivaldo, C., Liberale, L., Carbone, F., Montecucco, F., Bastianon, M., Mastrogiacomo, M., Palombo, D., Pratesi, G., & Barisione, C. (2026) · Basic Research in Cardiology · doi:10.1007/s00395-026-01164-x · Cited by 2
Tu, Z., Wei, Y., Liao, Y., Wan, Z., Zhou, Z., & Guo, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1816199 · Cited by 2
Ridker, P. M. (2026) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2026.120687 · Cited by 2
Borghini, A., Palazzo, M., Tonacci, A., Minichilli, F., Wu, H., & Gorini, F. (2026) · Antioxidants · doi:10.3390/antiox15070786 · Cited by 2
Targeting Inflammation in Atherosclerotic Cardiovascular Disease: Mechanisms and Emerging Therapies
Spindler, M. P., Libby, P., & Ridker, P. M. (2026) · Immunological Reviews · doi:10.1111/imr.70151 · Cited by 3
Kondo, S., Suzuki, R., Nakashima, Y., & Mochizuki, K. (2022) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2022.101325 · Cited by 2
Nishibe, T., Kano, M., Akiyama, S., Koizumi, J., & Dardik, A. (2023) · Vascular and Endovascular Surgery · doi:10.1177/15385744231204238 · Cited by 2
Evaluation of β2-microglobulin in the condition and prognosis of psoriasis patients
Han, L., Gan, Y., Du, J., Hu, Y., Chen, Y., Huang, Q., Zhang, Z., Yawalkar, N., Yan, K., & Wang, Z. (2024) · Journal of Dermatological Treatment · doi:10.1080/09546634.2024.2377665 · Cited by 2
Zhou, L., Sun, Q. P., & Cao, D. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117606 · Cited by 2
Zhang, H., Wang, Y., Liu, M., Yao, Q., Shen, S., Gang, Q., Jiang, H., Lun, Y., & Zhang, J. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70220 · Cited by 2
Metadata
- Authors
- Tabas, I., & Lichtman, A. H.
- Affiliations
- Columbia University Irving Medical Center (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Tabas, Ira
- Lichtman, Andrew H.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2017-10
- Volume
- 47
- Issue
- 4
- Pages
- 621-634
- ISSN
- 1074-7613 (ISSN-L)
- PMC
- PMC5747297
- OpenAlex
- W2766451938
- Cited by
- 646
- References
- 155
- Citations by year
- 2026: 53 · 2025: 57 · 2024: 72 · 2023: 65 · 2022: 86 · 2021: 102 · 2020: 80 · 2019: 78 · 2018: 49 · 2017: 4
- FWCI
- 6.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Immunity (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01 HL132412, HL127464, HL075662, P01 HL087123, R01 HL087282, HL131862)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- atherosclerosis, monocytes/macrophages, T cells, innate immune response, adaptive immune response, damage-associated molecular patterns, apolipoprotein B-containing lipoproteins, macrophage activation, regulatory T cells, effector T cells, chronic inflammation, thrombosis, hematopoiesis, cholesterol, phenotypic plasticity, aging, atherosclerosis treatment
- MeSH terms
- Animals, Humans, Immunity, Innate, Lipoproteins, Macrophages, Monocytes, T-Lymphocytes, Models, Immunological, Atherosclerosis, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review